Quarterly profits and revenue at big American companies are poised to decline for the first time since the recession, as some industrial firms warn of a pullback in spending.

A best-selling antipsychotic drug soon could get so smart, patients can’t lie about taking it. The company that makes Abilify, a popular medication used to treat conditions including schizophrenia, bipolar disorder and major depression, is seeking approval from the Food and Drug Administration to insert the pills with a chip alerting doctors if a patient fails to ingest it at the right times.

It may soon cost you less to fly to Europe than to take your spouse out to dinner. The chief executive of Norwegian Air Shuttle ASA – a budget European carrier – said that, as early as 2017, he hopes to sell one-way tickets from certain cities in the U.S. to Europe starting at just $69.

Much more is highlighted in A Look Ahead.